An interventional study of Remote temperature monitoring device and Home temperature monitoring by a nurse in Oncopediatrics and Febrile Neutropenia, sponsored by Centre Hospitalier Universitaire de la Réunion. Not yet recruiting. Open to participants aged 0 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Centre Hospitalier Universitaire de la Réunion · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this clinical trial is to evaluate the feasibility of the study, measured by the acceptability rate of patients to be recruited in a study proposing temperature monitoring at home, by a remote monitoring device or by the visit of an IDE at home (in association with the usual educational sessions), to children at risk of febrile neutropenia, from families with psycho-social vulnerabilities.
The main questions it aims to answer are:
Researchers will compare :
147 studies on the registry are indexed under Febrile Neutropenia; 36 are open to participants now.
This study's planned enrollment of 30 is below the median of 120 across 95 interventional studies indexed under Febrile Neutropenia.
Browse Febrile Neutropenia studies →Centre Hospitalier Universitaire de la Réunion is the lead sponsor of 141 studies on the registry; 37 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
patient
Exclusion Criteria:
Patient:
Device: Remote temperature monitoring device
Diagnostic Test: Home temperature monitoring by a nurse
* Use of the Tucky® remote monitoring device for continuous temperature monitoring at home, * In combination with education sessions on temperature monitoring and the device.
* Home temperature monitoring by a nyrse, twice a day, * In association with education sessions on temperature monitoring.
study acceptability rate
number of patients included/number of eligible patients offered the study.
Time frame: 24 months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Dec 2028, 24 months later.
Of 16 interventional studies with no phase under Febrile Neutropenia, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 24 months is close to that.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 23, 2026: start May 2026 → Dec 2026, primary completion May 2028 → Dec 2028 and completion May 2028 → Dec 2028.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de la Réunion →